Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies - PubMed (original) (raw)
doi: 10.1038/mp.2009.125. Epub 2009 Dec 29.
J Shi, J B Kraft, J B Potash, J A Knowles, M M Weissman, H A Garriock, J S Yokoyama, P J McGrath, E J Peters, W A Scheftner, W Coryell, W B Lawson, D Jancic, P V Gejman, A R Sanders, P Holmans, S L Slager, D F Levinson, S P Hamilton
Affiliations
- PMID: 20038947
- PMCID: PMC2888856
- DOI: 10.1038/mp.2009.125
Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies
S I Shyn et al. Mol Psychiatry. 2011 Feb.
Abstract
We report a genome-wide association study (GWAS) of major depressive disorder (MDD) in 1221 cases from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and 1636 screened controls. No genome-wide evidence for association was detected. We also carried out a meta-analysis of three European-ancestry MDD GWAS data sets: STAR*D, Genetics of Recurrent Early-onset Depression and the publicly available Genetic Association Information Network-MDD data set. These data sets, totaling 3957 cases and 3428 controls, were genotyped using four different platforms (Affymetrix 6.0, 5.0 and 500 K, and Perlegen). For each of 2.4 million HapMap II single-nucleotide polymorphisms (SNPs), using genotyped data where available and imputed data otherwise, single-SNP association tests were carried out in each sample with correction for ancestry-informative principal components. The strongest evidence for association in the meta-analysis was observed for intronic SNPs in ATP6V1B2 (P=6.78 x 10⁻⁷), SP4 (P=7.68 x 10⁻⁷) and GRM7 (P=1.11 x 10⁻⁶). Additional exploratory analyses were carried out for a narrower phenotype (recurrent MDD with onset before age 31, N=2191 cases), and separately for males and females. Several of the best findings were supported primarily by evidence from narrow cases or from either males or females. On the basis of previous biological evidence, we consider GRM7 a strong MDD candidate gene. Larger samples will be required to determine whether any common SNPs are significantly associated with MDD.
Figures
Figure 1. Overview of STAR*D GWAS results for 260,474 SNPs
(A) Q-Q plot of observed vs. expected -log (_P_-value). λ, the genomic inflation factor, is estimated at 1.022. (B) Manhattan plot of all results by chromosomal location.
Figure 2. Meta-analysis results
Shown are association test results (-log10[_P_-values] on the Y-axis) for the meta-analyses of the GenRED, STAR*D and GAIN MDD datasets, for the Broad phenotype (primary analysis) and the Narrow phenotype (recurrent early-onset cases). The X-axis shows the start position of each chromosome. Plots for males and females separately are available in online Supplementary Figures S15 and S16.
Figure 3. Best-supported regions in the meta-analysis
Shown are plots of association test results (males+females unless noted otherwise) for the three gene-containing regions with the lowest _P_-values in the primary (Broad) meta-analysis (see Table 5): ATP6V1B2 (Panel A), SP4 (B), GRM7 (C). Shown in each panel from top to bottom are: an ideogram of the chromosome with the plotted area marked in red; locations in base pairs; RefSeq genes with arrows representing direction of transcription; association test results as the -log10 of the _P_-value for each genotyped and imputed SNP; and color-coded marker-marker linkage disequiibrium results for phased HapMap II CEU genotypes (UCSC browser). Similar plots for additional top findings are available as online Supplementary Figures.
Similar articles
- Genome-wide association study of recurrent early-onset major depressive disorder.
Shi J, Potash JB, Knowles JA, Weissman MM, Coryell W, Scheftner WA, Lawson WB, DePaulo JR Jr, Gejman PV, Sanders AR, Johnson JK, Adams P, Chaudhury S, Jancic D, Evgrafov O, Zvinyatskovskiy A, Ertman N, Gladis M, Neimanas K, Goodell M, Hale N, Ney N, Verma R, Mirel D, Holmans P, Levinson DF. Shi J, et al. Mol Psychiatry. 2011 Feb;16(2):193-201. doi: 10.1038/mp.2009.124. Epub 2010 Feb 2. Mol Psychiatry. 2011. PMID: 20125088 Free PMC article. - Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts.
Muglia P, Tozzi F, Galwey NW, Francks C, Upmanyu R, Kong XQ, Antoniades A, Domenici E, Perry J, Rothen S, Vandeleur CL, Mooser V, Waeber G, Vollenweider P, Preisig M, Lucae S, Müller-Myhsok B, Holsboer F, Middleton LT, Roses AD. Muglia P, et al. Mol Psychiatry. 2010 Jun;15(6):589-601. doi: 10.1038/mp.2008.131. Epub 2008 Dec 23. Mol Psychiatry. 2010. PMID: 19107115 - A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studies.
Chang LC, Jamain S, Lin CW, Rujescu D, Tseng GC, Sibille E. Chang LC, et al. PLoS One. 2014 Mar 7;9(3):e90980. doi: 10.1371/journal.pone.0090980. eCollection 2014. PLoS One. 2014. PMID: 24608543 Free PMC article. - A new lead from genetic studies in depressed siblings: assessing studies of chromosome 3.
Hamilton SP. Hamilton SP. Am J Psychiatry. 2011 Aug;168(8):783-9. doi: 10.1176/appi.ajp.2011.11060835. Am J Psychiatry. 2011. PMID: 21813496 Review. - Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder.
Li X, Luo Z, Gu C, Hall LS, McIntosh AM, Zeng Y, Porteous DJ, Hayward C, Li M, Yao YG, Zhang C, Luo XJ; 23andMe Research Team7. Li X, et al. Neuropsychopharmacology. 2018 Sep;43(10):2146-2153. doi: 10.1038/s41386-018-0078-9. Epub 2018 Apr 27. Neuropsychopharmacology. 2018. PMID: 29728651 Free PMC article. Review.
Cited by
- The role of cell adhesion molecule IgSF9b at the inhibitory synapse and psychiatric disease.
Clarin JD, Reddy N, Alexandropoulos C, Gao WJ. Clarin JD, et al. Neurosci Biobehav Rev. 2024 Jan;156:105476. doi: 10.1016/j.neubiorev.2023.105476. Epub 2023 Nov 29. Neurosci Biobehav Rev. 2024. PMID: 38029609 Review. - Connecting Dots between Mitochondrial Dysfunction and Depression.
Khan M, Baussan Y, Hebert-Chatelain E. Khan M, et al. Biomolecules. 2023 Apr 20;13(4):695. doi: 10.3390/biom13040695. Biomolecules. 2023. PMID: 37189442 Free PMC article. Review. - Associating broad and clinically defined polygenic scores for depression with depression-related phenotypes.
McGeary JE, Benca-Bachman CE, Risner VA, Beevers CG, Gibb BE, Palmer RHC. McGeary JE, et al. Sci Rep. 2023 Apr 21;13(1):6534. doi: 10.1038/s41598-023-33645-7. Sci Rep. 2023. PMID: 37085695 Free PMC article. - GRM7 gene mutations and consequences for neurodevelopment.
Freitas GA, Niswender CM. Freitas GA, et al. Pharmacol Biochem Behav. 2023 Apr;225:173546. doi: 10.1016/j.pbb.2023.173546. Epub 2023 Mar 30. Pharmacol Biochem Behav. 2023. PMID: 37003303 Free PMC article. Review. - Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases.
Santiago JA, Quinn JP, Potashkin JA. Santiago JA, et al. Int J Mol Sci. 2023 Mar 21;24(6):5909. doi: 10.3390/ijms24065909. Int J Mol Sci. 2023. PMID: 36982982 Free PMC article.
References
- World Health Organization . The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020; summary. Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank; Distributed by Harvard University Press; Cambridge, Mass.: 1996. p. 43.
- Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008 Jan 3;358(1):55–68. - PubMed
- Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000 Oct;157(10):1552–1562. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH072802/MH/NIMH NIH HHS/United States
- T32 MH19126/MH/NIMH NIH HHS/United States
- T32 MH19552/MH/NIMH NIH HHS/United States
- T32 MH019126/MH/NIMH NIH HHS/United States
- MH072802/MH/NIMH NIH HHS/United States
- N01MH90003/MH/NIMH NIH HHS/United States
- T32 MH020006/MH/NIMH NIH HHS/United States
- R01 MH072802-04/MH/NIMH NIH HHS/United States
- F32 MH082562/MH/NIMH NIH HHS/United States
- G0800509/MRC_/Medical Research Council/United Kingdom
- T32 MH019552/MH/NIMH NIH HHS/United States
- U54 RR020278/RR/NCRR NIH HHS/United States
- R25 MH060482/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources